drugset / Trial / NCT03326856
ET-01 in Subjects With Lateral Canthal Lines
RandomizedSequentialQuadruple-blindTreatment
Summary
This study tests an investigational drug formulation called ET-01, botulinum toxin, Type A, topical, in lateral canthal lines (LCL).
Timeline
- Start
- 2017-10-25
- Primary completion
- 2018-06-11
- Completion
- 2018-11-14
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | — | Topical |